I think [hope] this study is equivalent to a phase 11 study, and can be used as such for the pharmaceutical version. If so the company should be able to advance the drug version rather quickly.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.